Desserud Kari F, Bukholm Ida, Søreide Jon Arne
Department of Gastrointestinal Surgery, Stavanger University Hospital, Stavanger, Norway.
The Norwegian System of Compensation to Patients (NPE), Oslo, Norway.
Anticancer Res. 2017 Oct;37(10):5667-5671. doi: 10.21873/anticanres.12002.
Management of patients with neuroendocrine tumors of the gastrointestinal tract or pancreas (GEP-NENs) poses diagnostic and therapeutic challenges. This study described the medico-legal claims reported to a national governmental system that oversees compensation to patients with GEP-NENs Materials and Methods: An electronic search of the Norwegian System of Compensation to Patients database was performed to identify claims evaluated between 2005-2016. The clinical information and the medico-legal evaluation were reviewed.
We identified seven patients, five women and two men, with a median age of 57 (range=47-73) years. Delayed diagnosis (median diagnostic delay of 18 (range=6-48) months) was the main cause for claims in six out of the seven patients). Four patients received financial compensation based on the claim judgement.
This review of claims that were evaluated by the Norwegian System of Compensation to Patients showed that a timely diagnosis of GEP-NENs remains a clinical challenge.
